Article metrics

Extended report
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy

 

Online download statistics by month:

Online download statistics by month: August 2015 to August 2023

AbstractFullPdf
Aug 201541361117
Sep 20151083700530
Oct 2015198131103
Nov 201511314493
Dec 2015124126120
Jan 201614111778
Feb 20161019673
Mar 2016938171
Apr 20169811694
May 2016211144120
Jun 2016236125112
Jul 2016120163101
Aug 201611519972
Sep 201610920383
Oct 201611617486
Nov 20168711986
Dec 20161656232223
Jan 2017946203176
Feb 201713212578
Mar 20171620592
Apr 20171237372
May 20171526679
Jun 20176421791
Jul 201725724974
Aug 201728525871
Sep 201728323663
Oct 201727426187
Nov 2017305274121
Dec 201719918260
Jan 201820518470
Feb 201817314973
Mar 201818614757
Apr 201834930247
May 201817815535
Jun 201818817142
Jul 201819918152
Aug 201822320758
Sep 201824219371
Oct 201824524174
Nov 201827026859
Dec 201825124559
Jan 201920620473
Feb 201920519966
Mar 201915014580
Apr 201910910775
May 201912412483
Jun 2019595849
Jul 20191118163
Aug 2019977873
Sep 2019926651
Oct 20191076858
Nov 2019997446
Dec 2019997463
Jan 20201239760
Feb 20201349455
Mar 2020946541
Apr 2020614336
May 20201268256
Jun 2020916945
Jul 2020815849
Aug 2020675041
Sep 20201258741
Oct 2020966462
Nov 2020967861
Dec 2020917154
Jan 2021906063
Feb 2021977648
Mar 2021766348
Apr 2021654947
May 2021675439
Jun 2021545238
Jul 2021474743
Aug 2021585745
Sep 2021414043
Oct 2021987560
Nov 2021654958
Dec 2021595431
Jan 2022724236
Feb 2022695024
Mar 2022685224
Apr 2022878118
May 202211310330
Jun 2022775515
Jul 2022574918
Aug 2022867222
Sep 2022705724
Oct 2022746325
Nov 2022836116
Dec 2022564614
Jan 2023594618
Feb 2023855817
Mar 2023796320
Apr 2023653725
May 2023553934
Jun 2023503813
Jul 2023533829
Aug 2023603843
Total15389121236332